Gyre Therapeutics
GYRE
#5533
Rank
C$1.41 B
Marketcap
$16.43
Share price
-8.99%
Change (1 day)
-5.80%
Change (1 year)

EPS for Gyre Therapeutics (GYRE)

EPS in 2024 (TTM): $0.14

According to Gyre Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.97. In 2023 the company made an earnings per share (EPS) of -$1.97 a decrease over its 2022 EPS that were of $0.006094.

EPS history for Gyre Therapeutics from 2021 to 2024

Annual EPS

Year EPS Change
2024 (TTM)$0.14-107.28%
2023-$1.97-32451.8%
2022$0.006094-90.93%
2021$0.06715